Franopolis
    vs

    Franchise opportunities compared

    Medicap Pharmacies vs NexGenEsis Healthcare

    Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.

    Medicap Pharmacies2025 FDDNexGenEsis Healthcare2025 FDD

    Initial investment · Item 7

    Medicap Pharmacies

    $130,000 – $546,653

    2025 FDD · Item 7

    NexGenEsis Healthcare

    $124,500 – $362,695

    2025 FDD · Item 7

    Initial franchise fee · Item 5

    Medicap Pharmacies

    $0.00

    2025 FDD · Item 5 · PDF p. 18 · printed p. 10

    NexGenEsis Healthcare

    Not available

    Royalty · Item 6

    Medicap Pharmacies

    $599

    2025 FDD · Item 6 · PDF p. 19 · printed p. 11

    NexGenEsis Healthcare

    $7.00

    2025 FDD · Item 6 · PDF p. 19

    Before you compare

    • Both sets of figures come from 2025 FDDs.
    • Medicap Pharmacies and NexGenEsis Healthcare disclose more than one business format, so the investment range spans formats; the full report breaks them out.
    • Only NexGenEsis Healthcare has reviewed Item 19 figures here.

    Financial commitment

    Estimated initial investment (Item 7)

    Medicap Pharmacies

    $130,000 – $546,653
    2025 FDD · Item 7

    NexGenEsis Healthcare

    $124,500 – $362,695
    2025 FDD · Item 7
    Standard initial franchise fee (Item 5)

    Medicap Pharmacies

    $0.00
    2025 FDD · Item 5 · PDF p. 18 · printed p. 10

    NexGenEsis Healthcare

    Not available
    No single standard fee identified
    Royalty (Item 6)

    Medicap Pharmacies

    $599
    Continuing license fee — fixed monthly alternative
    2025 FDD · Item 6 · PDF p. 19 · printed p. 11

    NexGenEsis Healthcare

    $7.00
    Royalty rate
    2025 FDD · Item 6 · PDF p. 19
    Brand / advertising fund (Item 6)

    Medicap Pharmacies

    $310
    PMA digital marketing — low monthly
    2025 FDD · Item 6 · PDF p. 20 · printed p. 12

    NexGenEsis Healthcare

    $1.00
    Brand Fund annual increase cap
    2025 FDD · Item 6 · PDF p. 19

    System scale & health

    Total outlets (Item 20)

    Medicap Pharmacies

    Not available
    No reviewed outlet counts

    NexGenEsis Healthcare

    Not available
    No reviewed outlet counts
    Net outlet change (Item 20)

    Medicap Pharmacies

    Not available
    Only one year reported

    NexGenEsis Healthcare

    Not available
    Only one year reported
    Outlet exits (Item 20)

    Medicap Pharmacies

    Not available
    No complete exit records for a year

    NexGenEsis Healthcare

    Not available
    No complete exit records for a year
    Franchising since (Item 1)

    Medicap Pharmacies

    Not available
    Not in reviewed records

    NexGenEsis Healthcare

    Not available
    Not in reviewed records
    Franchisor founded (Item 1)

    Medicap Pharmacies

    Not available
    Not in reviewed records

    NexGenEsis Healthcare

    Not available
    Not in reviewed records

    Financial performance (Item 19), by location group

    Medicap Pharmacies

    Not disclosed — no Item 19 financial performance representation

    NexGenEsis Healthcare
    Franchised (1 locations) — EBITDA and costs and other measures and revenue and profit
    -$64,254.00
    other Adjusted EBITDA
    2025 FDD · Item 19 · PDF p. 63
    Locations counted not stated in the reviewed record
    3 locations
    other Affiliate Reporting Group reporting locations
    2025 FDD · Item 19 · PDF p. 61

    Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.

    Medicap Pharmacies vs NexGenEsis Healthcare: common questions

    Which costs less to open, Medicap Pharmacies or NexGenEsis Healthcare?
    Medicap Pharmacies: $130,000 – $546,653 (2025 FDD · Item 7); NexGenEsis Healthcare: $124,500 – $362,695 (2025 FDD · Item 7). These are each franchisor's Item 7 estimated initial investment. The low end of the disclosed estimate is lower for NexGenEsis Healthcare. At least one range spans several business formats. Estimates are not quotes, and the FDD years may differ.
    How do Medicap Pharmacies and NexGenEsis Healthcare royalties compare?
    Medicap Pharmacies: $599 (2025 FDD · Item 6 · PDF p. 19 · printed p. 11); NexGenEsis Healthcare: $7.00 (2025 FDD · Item 6 · PDF p. 19). Royalties as disclosed in Item 6; other recurring fees are listed separately.
    Do Medicap Pharmacies and NexGenEsis Healthcare disclose financial performance (Item 19)?
    Medicap Pharmacies makes no Item 19 financial performance representation; NexGenEsis Healthcare has reviewed Item 19 figures for 2 location groups. Different location groups are not directly comparable, and revenue is not profit.

    Answers restate the reviewed figures above. Not a ranking or recommendation.

    How Franopolis reviews FDD figures

    Keep researching

    Full Medicap Pharmacies report

    Every reviewed fee, Item 19 group, outlet table and territory disclosure

    Full NexGenEsis Healthcare report

    Every reviewed fee, Item 19 group, outlet table and territory disclosure

    Compare Medicap Pharmacies with

    Compare NexGenEsis Healthcare with

    Add a third brand

    Compare up to four side by side

    Explore by brand

    Filter every published report

    FDD glossary

    Plain-language meaning of each Item